{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:07Z","timestamp":1707525367413},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,6]]},"DOI":"10.7759\/cureus.48358","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T13:22:39Z","timestamp":1699276959000},"source":"Crossref","is-referenced-by-count":0,"title":["Intradermal Immunoglobulin E (IgE) Injection in a Specific Interval With Emollient in the Control of Chronic Idiopathic Urticaria and Allergic Rhinitis"],"prefix":"10.7759","author":[{"given":"Farhana Rashid","family":"Sumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Abul Kalam A","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Abdul","family":"Mukit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarker Mahbub  A","family":"Shamim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehnuma","family":"Tabassum Orthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saimun","family":"Jesmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA\u00b2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier T","year":"2018","unstructured":"Zuberbier T, Aberer W, Asero R, et al.. The EAACI\/GA\u00b2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018, 73:1393-414. 10.1111\/all.13397","journal-title":"Allergy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-58713-3_29-1","article-title":"Urticaria and angioedema","author":"Wedi B","year":"2020","unstructured":"Wedi B. Urticaria and angioedema. Braun-Falco's Dermatology. Plewig G, French L, Ruzicka T, Kaufmann R, Hertl M (ed): Springer Verlag GmbH, Berlin, Heidelberg; 2020. 10.1007\/978-3-662-58713-3_29-1"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould HJ","year":"2008","unstructured":"Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008, 8:205-17. 10.1038\/nri2273","journal-title":"Nat Rev Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00175","article-title":"Current strategies to inhibit high affinity Fc\u03b5RI-mediated signaling for the treatment of allergic disease","volume":"10","author":"Gomez G","year":"2019","unstructured":"Gomez G. Current strategies to inhibit high affinity Fc\u03b5RI-mediated signaling for the treatment of allergic disease. Front Immunol. 2019, 10:175. 10.3389\/fimmu.2019.00175","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3447","article-title":"Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta-analysis of \"real-world\" evidence","volume":"155","author":"Tharp MD","year":"2019","unstructured":"Tharp MD, Bernstein JA, Kavati A, et al.. Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta-analysis of \"real-world\" evidence. JAMA Dermatol. 2019, 155:29-38. 10.1001\/jamadermatol.2018.3447","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2016.04.009","article-title":"Allergic rhinitis","volume":"43","author":"Kakli HA","year":"2016","unstructured":"Kakli HA, Riley TD. Allergic rhinitis. Prim Care. 2016, 43:465-75. 10.1016\/j.pop.2016.04.009","journal-title":"Prim Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12494","article-title":"BSACI guideline for the management of chronic urticaria and angioedema","volume":"45","author":"Powell RJ","year":"2015","unstructured":"Powell RJ, Leech SC, Till S, Huber PA, Nasser SM, Clark AT. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015, 45:547-65. 10.1111\/cea.12494","journal-title":"Clin Exp Allergy"},{"key":"ref8","article-title":"Treatment of chronic urticaria","volume":"17","author":"Juraki\u0107 Ton\u010di\u0107 R","year":"2009","unstructured":"Juraki\u0107 Ton\u010di\u0107 R, Lipozen\u010di\u0107 J, Marinovi\u0107 B. Treatment of chronic urticaria. Acta Dermatovenerol Croat. 2009, 17:305-22.","journal-title":"Acta Dermatovenerol Croat"},{"key":"ref9","article-title":"Histaglobin treatment of chronic urticaria and occupational dermatoses [Article in Russian]","volume":"47","author":"Shevliakov LV","year":"1973","unstructured":"Shevliakov LV. Histaglobin treatment of chronic urticaria and occupational dermatoses [Article in Russian]. Vestn Dermatol Venerol. 1973, 47:62-3.","journal-title":"Vestn Dermatol Venerol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.19861","article-title":"Prevention of multiple drug allergy by histaglobulin","volume":"38","author":"Mohanty M","year":"2006","unstructured":"Mohanty M, Mohapatra S, Pattnaik KP, et al.. Prevention of multiple drug allergy by histaglobulin. Indian J Pharmacol. 2006, 38:68-9. 10.4103\/0253-7613.19861","journal-title":"Indian J Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2012.4.6.326","article-title":"Treatment of chronic spontaneous urticaria","volume":"4","author":"Kaplan AP","year":"2012","unstructured":"Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2012, 4:326-31. 10.4168\/aair.2012.4.6.326","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA(2) LEN\/EDF\/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier T","year":"2014","unstructured":"Zuberbier T, Aberer W, Asero R, et al.. The EAACI\/GA(2) LEN\/EDF\/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014, 69:868-87. 10.1111\/all.12313","journal-title":"Allergy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijced.2019.052","article-title":"Single centre experience with histaglobin as an adjunctive treatment of chronic urticaria: a post marketing surveillance study","volume":"5","author":"Godse K","year":"2019","unstructured":"Godse K, Tare D, Gawali R. Single centre experience with histaglobin as an adjunctive treatment of chronic urticaria: a post marketing surveillance study. IP Indian J Clin Exp Dermatol. 2019, 5:243-8. 10.18231\/j.ijced.2019.052","journal-title":"IP Indian J Clin Exp Dermatol"},{"key":"ref14","article-title":"Estimation of serum immunoglobulin E (IgE) level in allergic asthma and allergic rhinitis patients before and after treatment","volume":"2","author":"Manohar S","year":"2012","unstructured":"Manohar S, Selvakumaran R. Estimation of serum immunoglobulin E (IgE) level in allergic asthma and allergic rhinitis patients before and after treatment. Eur J Exp Biol. 2012, 2:2199-205.","journal-title":"Eur J Exp Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.182884","article-title":"Weekly injection of histaglobulin produces long-term remission in chronic urticaria: a prospective clinical study","volume":"48","author":"Rajesh G","year":"2016","unstructured":"Rajesh G, Keerthi S, Karthikeyan K, Venkatesan M. Weekly injection of histaglobulin produces long-term remission in chronic urticaria: a prospective clinical study. Indian J Pharmacol. 2016, 48:292-7. 10.4103\/0253-7613.182884","journal-title":"Indian J Pharmacol"},{"key":"ref16","article-title":"Therapeutic effectiveness of histaglobin preparations in patients with allergic rhinitis and chronic urticaria [Article in Russian]","volume":"71","author":"Gushchin IS","year":"1999","unstructured":"Gushchin IS, Luss LV, Il'ina NI, Larina ON, Pakhomova LA. Therapeutic effectiveness of histaglobin preparations in patients with allergic rhinitis and chronic urticaria [Article in Russian]. Ter Arkh. 1999, 71:57-62.","journal-title":"Ter Arkh"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/179997-intradermal-immunoglobulin-e-ige-injection-in-a-specific-interval-with-emollient-in-the-control-of-chronic-idiopathic-urticaria-and-allergic-rhinitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:51Z","timestamp":1707509331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/179997-intradermal-immunoglobulin-e-ige-injection-in-a-specific-interval-with-emollient-in-the-control-of-chronic-idiopathic-urticaria-and-allergic-rhinitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,6]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.48358","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,6]]}}}